Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathways

被引:61
作者
Burns, W. C. [1 ]
Velkoska, E. [2 ]
Dean, R. [2 ]
Burrell, L. M. [2 ]
Thomas, M. C. [1 ]
机构
[1] Baker IDI Heart & Diabet Inst, Danielle Alberti Mem Ctr Diabet Complicat, Melbourne, Vic 8008, Australia
[2] Univ Melbourne, Dept Med, Heidelberg Hts, Vic, Australia
关键词
renin-angiotensin system; epithelial-to-mesenchymal transition; fibrosis; proximal tubule; GROWTH-FACTOR-BETA; RENAL INJURY; MYOFIBROBLAST TRANSDIFFERENTIATION; RECEPTOR ANTAGONIST; ADVANCED GLYCATION; MESANGIAL CELLS; TRANSITION; FIBROSIS; NEPHROPATHY; PROTEIN;
D O I
10.1152/ajprenal.00538.2009
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Burns WC, Velkoska E, Dean R, Burrell LM, Thomas MC. Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathways. Am J Physiol Renal Physiol 299: F585-F593, 2010. First published June 16, 2010; doi:10.1152/ajprenal.00538.2009.-Epithelial-to-mesenchymal transformation (EMT) of tubular cells into a myofibroblastic phenotype is an important mediator of renal scarring in chronic nephropathy. This study examines the role of the renin-angiotensin system (RAS) in this process. NRK-52E cells were exposed to angiotensin (ANG) II and ANG 1-7 in the presence or absence of inhibitors and agonists of RAS signaling. EMT was assessed at 3 days by expression of alpha-smooth muscle actin (alpha-SMA) and E-cadherin and the induction of a myofibroblastic phenotype. Expression of fibrogenic growth factors and matrix proteins was assessed by RT-PCR and immunofluorescence microscopy. To confirm findings in vivo, rats were also infused with ANG 1-7 (24 mu g.kg(-1).h(-1)) or saline via an osmotic minipump for 10 days, and renal fibrogenesis was then assessed. Treatment of NRK-52E cells with ANG II induced characteristic changes of EMT. Selective blockade of the AT(1) receptor or the AT(2) receptor failed to inhibit ANG II-induced EMT. However, blockade of the ANG 1-7 receptor, Mas-1, was able to prevent ANG II-dependent EMT. To confirm these findings, both ANG 1-7 and the selective Mas receptor agonist, AVE-0991, were able to induce NRK-52E cells in a dose-dependent manner. Exposing cells to recombinant ACE2 was also able to induce EMT. In addition, an infusion of ANG 1-7 induced the tubular expression of alpha-SMA and the expression of matrix proteins in the kidney. ANG II is a potent stimulus for EMT, but not through conventional pathways. This study points to the possible limitations of conventional RAS blockade, which not only fails to antagonize this pathway, but also may enhance it via augmenting the synthesis of ANG 1-7.
引用
收藏
页码:F585 / F593
页数:9
相关论文
共 39 条
[1]   Interactions of transforming growth factor-β and angiotensin II in renal fibrosis [J].
Border, WA ;
Noble, NA .
HYPERTENSION, 1998, 31 (01) :181-188
[2]   Intrarenal infusion of angiotensin-(1-7) modulates renal functional responses to exogenous angiotensin II in the rat [J].
Bürgelová, M ;
Kramer, HJ ;
Teplan, V ;
Velicková, G ;
Vítko, S ;
Heller, J ;
Maly, J ;
Cervenka, L .
KIDNEY & BLOOD PRESSURE RESEARCH, 2002, 25 (04) :202-210
[3]   Connective tissue growth factor plays an important role in advance glycation end product-induced tubular epithelial-to-mesenchymal transition: Implications for diabetic renal disease [J].
Burns, Wendy C. ;
Twigg, Stephen M. ;
Forbes, Josephine M. ;
Pete, Josefa ;
Tikellis, Christos ;
Thallas-Bonke, Vicki ;
Thomas, Merlin C. ;
Cooper, Mark E. ;
Kantharidis, Phillip .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (09) :2484-2494
[4]   Halting the progression of chronic nephropathy [J].
Campbell, RC ;
Ruggenenti, P ;
Remuzzi, G .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (11) :S190-S195
[5]   Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation [J].
Carvajal, Gisselle ;
Rodriguez-Vita, Juan ;
Rodrigues-Diez, Raquel ;
Sanchez-Lopez, Elsa ;
Ruperez, Monica ;
Cartier, Cecile ;
Esteban, Vanesa ;
Ortiz, Alberto ;
Egido, Jesus ;
Mezzano, Sergio A. ;
Ruiz-Ortega, Marta .
KIDNEY INTERNATIONAL, 2008, 74 (05) :585-595
[6]   Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials [J].
Chaturvedi, Nish ;
Porta, Massimo ;
Klein, Ronald ;
Orchard, Trevor ;
Fuller, John ;
Parving, Hans Henrik ;
Bilous, Rudy ;
Sjolie, Anne Katrin .
LANCET, 2008, 372 (9647) :1394-1402
[7]   Influence of connective tissue growth factor antisense oligonucleotide on angiotensin II-induced epithelial mesenchymal transition in HK2 cells [J].
Chen, Long ;
Liu, Bi-cheng ;
Zhang, Xiao-liang ;
Zhang, Jian-dong ;
Liu, Hong ;
Li, Min-xia .
ACTA PHARMACOLOGICA SINICA, 2006, 27 (08) :1029-1036
[8]   Vasoactive hormones and renal sclerosis - Discussion [J].
Egido, J .
KIDNEY INTERNATIONAL, 1996, 49 (02) :578-597
[9]   Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro [J].
Fan, JM ;
Ng, YY ;
Hill, PA ;
Nikolic-Paterson, DJ ;
Mu, W ;
Atkins, RC ;
Lan, HY .
KIDNEY INTERNATIONAL, 1999, 56 (04) :1455-1467
[10]   Renin-angiotensin system revisited [J].
Fyhrquist, F. ;
Saijonmaa, O. .
JOURNAL OF INTERNAL MEDICINE, 2008, 264 (03) :224-236